Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysis

被引:104
|
作者
Zhang, SX
Feng, J
Kuo, SC
Brossi, A
Hamel, E
Tropsha, A [1 ]
Li, KH
机构
[1] Univ N Carolina, Sch Pharm, Nat Prod Lab, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Pharm, Lab Mol Modeling, Chapel Hill, NC 27599 USA
[3] China Med Coll, Grad Inst Pharmaceut Chem, Taichung 400, Taiwan
[4] NCI, Lab Drug Discovery Res & Dev, Dev Therapeut Program, Div Canc Treatment & Diag,Frederick Canc Res Ctr, Ft Detrick, MD 21702 USA
关键词
D O I
10.1021/jm990333a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibitors of tubulin polymerization interacting at the colchicine binding site are potential anticancer agents. We have been involved in the synthesis of a number of colchicine site agents, such as thiocolchicinoids and allocolchicinoids, which are colchicine analogues, and 2-phenylquinolones and 2-aryl-naphthyridinones, which are the amino analogue a of cytotoxic antimitotic flavonoids. The most cytotoxic of the latter compounds strongly inhibit binding of radiolabeled colchicine to tubulin, and these agents therefore probably bind in the colchicine site of tubulin. We have applied conventional CoMFA and q(2)-GRS CoMFA to identify the essential structural requirements for increasing the ability of these compounds to form tubulin complexes. The CoMFA model for the training set of 51 compounds yielded cross-validated. R-2 (q(2)) values of 0.637 for conventional CoMFA and 0.692 for q(2)-GRS CoMFA. The predictive power of this model was confirmed by successful activity prediction for a test set of 53 compounds with known potencies as inhibitors of tubulin polymerization. The activities of 88% of the compounds were predicted with absolute value of residuals of less than 0.5. The predictive q(2) values were 0.546 for conventional CoMFA and 0.426 for q(2)-GRS CoMFA. The conventional CoMFA model with the highest predictive q(2) (0.546) was analyzed in detail in terms of underlying structure-activity relationships.
引用
收藏
页码:167 / 176
页数:10
相关论文
共 50 条
  • [1] Three-Dimensional Quantitative Structure-Activity Relationship of MT3 melatonin binding site ligands:: A Comparative Molecular Field Analysis
    Farce, Amaury
    Dilly, Sebastien
    Sabaouni, Ahmed
    Yous, Said
    Berthelot, Pascal
    Boutin, Jean A.
    Delagrange, Philippe
    Renard, Pierre
    Chavatte, Philippe
    [J]. QSAR & COMBINATORIAL SCIENCE, 2007, 26 (07): : 820 - 827
  • [2] Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: A comparative molecular field analysis study
    Sicsic, S
    Serraz, I
    Andrieux, J
    Bremont, B
    MatheAllainmat, M
    Poncet, A
    Shen, S
    Langlois, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (05) : 739 - 748
  • [3] Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis
    Shim, JY
    Collantes, ER
    Welsh, WJ
    Subramaniam, B
    Howlett, AC
    Eissenstat, MA
    Ward, SJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (23) : 4521 - 4532
  • [4] The structural model for tubulin polymerization inhibition by colchicine site agents: A three-dimensional quantitative structure-activity relationship study.
    Fan, Y
    Zhang, SJ
    Holden, S
    Partridge, JB
    Shen, SN
    Huang, TN
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U677 - U677
  • [5] Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis
    Farr, CD
    Tabet, MR
    Ball, WJ
    Fishwild, DM
    Wang, X
    Nair, AC
    Welsh, WJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (15) : 3257 - 3270
  • [6] A three-dimensional quantitative structure-activity relationship study of heparin-binding epidermal growth factor shedding inhibitors using comparative molecular field analysis
    Bursi, R
    Sawa, M
    Hiramatsu, Y
    Kondo, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 781 - 788
  • [7] Three-dimensional quantitative structure-activity, relationship modeling of γ-secretase inhibitors using molecular field analysis
    Sammi, Tarnvir
    Silalkari, Om
    Ravikumar, Muttineni
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (02) : 155 - 166
  • [8] Comparative three-dimensional quantitative structure-activity relationship study of safeners and herbicides
    Bordás, B
    Kömíves, T
    Szántó, Z
    Lopata, A
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (03) : 926 - 931
  • [9] Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis
    Paula, S
    Tabet, MR
    Keenan, SM
    Welsh, WJ
    Ball, WJ
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 325 (03) : 515 - 530
  • [10] Three-dimensional quantitative structure-activity relationship of interleukin 1-β converting enzyme inhibitors:: A comparative molecular field analysis study
    Kulkarni, SS
    Kulkarni, VM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) : 373 - 380